SVB Leerink Initiates Coverage on NeuroPace (NASDAQ:NPCE) :

Investment analysts at SVB Leerink began coverage on shares of NeuroPace (NASDAQ:NPCE – Get Free Report) in a research note issued to investors on Tuesday, Briefing.com reports. The firm set an “outperform” rating and a $22.00 price target on the stock. SVB Leerink’s price target indicates a potential upside of 49.15% from the company’s previous […]

Related Keywords

United States , Martha Morrell , Citigroup Inc , Cantor Fitzgerald , Kent Lake Capital , Morgan Stanley , Wells Fargo Company , Neuropace Company Profile , Vanguard Group Inc , Jpmorgan Chase Co , Neuropace Inc , Get Free Report , Street Capital , Wells Fargo , Lake Capital , Neuropace Daily , Neuropace , Nasdaq Npce , Npce , Medical , Initiated Coverage , Svb Leerink Llc ,